Literature DB >> 15485312

Therapy for recurrent malignant glioma in adults.

Maciej M Mrugala1, Santosh Kesari, Naren Ramakrishna, Patrick Y Wen.   

Abstract

Malignant gliomas are the most common form of primary brain tumors in adults. Although the prognosis remains poor, there has been recent progress in the treatment of these tumors. Standard therapy for patients with this disease will be reviewed, together with more novel approaches such as targeted molecular therapies, angiogenesis inhibitors, immunotherapies, gene therapies and intratumoral therapies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15485312     DOI: 10.1586/14737140.4.5.759

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  11 in total

1.  ERBB3, IGF1R, and TGFBR2 expression correlate with PDGFR expression in glioblastoma and participate in PDGFR inhibitor resistance of glioblastoma cells.

Authors:  Kang Song; Ye Yuan; Yong Lin; Yan-Xia Wang; Jie Zhou; Qu-Jing Gai; Lin Zhang; Min Mao; Xiao-Xue Yao; Yan Qin; Hui-Min Lu; Xiang Zhang; You-Hong Cui; Xiu-Wu Bian; Xia Zhang; Yan Wang
Journal:  Am J Cancer Res       Date:  2018-05-01       Impact factor: 6.166

2.  Perfusion-metabolism coupling in recurrent gliomas: a prospective validation study with 13N-ammonia and 18F-fluorodeoxyglucose PET/CT.

Authors:  Bangkim Chandra Khangembam; Sellam Karunanithi; Punit Sharma; Sudhir Suman Kc; Rajeev Kumar; Pramod Kumar Julka; Rakesh Kumar; Chandrasekhar Bal
Journal:  Neuroradiology       Date:  2014-07-03       Impact factor: 2.804

3.  Injectable SN-38-loaded Polymeric Depots for Cancer Chemotherapy of Glioblastoma Multiforme.

Authors:  Chawan Manaspon; Norased Nasongkla; Khuanjit Chaimongkolnukul; Pinunta Nittayacharn; Ketpat Vejjasilpa; Kanchana Kengkoom; Atthaporn Boongird; Suradej Hongeng
Journal:  Pharm Res       Date:  2016-08-05       Impact factor: 4.200

4.  Distinction between postoperative recurrent glioma and radiation injury using MR diffusion tensor imaging.

Authors:  Jun-Ling Xu; Yong-Li Li; Jian-Min Lian; She-wei Dou; Feng-Shan Yan; Hui Wu; Da-peng Shi
Journal:  Neuroradiology       Date:  2010-06-23       Impact factor: 2.804

Review 5.  Targeted molecular therapy of malignant gliomas.

Authors:  Santosh Kesari; Naren Ramakrishna; Claire Sauvageot; Charles D Stiles; Patrick Y Wen
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

6.  The Ubiquitin Ligase COP1 Promotes Glioma Cell Proliferation by Preferentially Downregulating Tumor Suppressor p53.

Authors:  Shenshan Zou; Yufu Zhu; Bin Wang; Fengyuan Qian; Xiang Zhang; Lei Wang; Chunling Fu; Hanmo Bao; Manyi Xie; Shangfeng Gao; Rutong Yu; Hengliang Shi
Journal:  Mol Neurobiol       Date:  2016-08-17       Impact factor: 5.590

7.  Growth factor receptors signaling in glioblastoma cells: therapeutic implications.

Authors:  Mia Carapancea; Oana Alexandru; Ani S Fetea; Laura Dragutescu; Juan Castro; Ada Georgescu; A Popa-Wagner; Magnus L Bäcklund; Rolf Lewensohn; Anica Dricu
Journal:  J Neurooncol       Date:  2008-11-30       Impact factor: 4.130

8.  Targeted molecular therapy of malignant gliomas.

Authors:  Santosh Kesari; Naren Ramakrishna; Claire Sauvageot; Charles D Stiles; Patrick Y Wen
Journal:  Curr Oncol Rep       Date:  2006-01       Impact factor: 5.075

9.  The Treatment of Malignant Gliomas.

Authors:  Mark R Gilbert; Monica Loghin
Journal:  Curr Treat Options Neurol       Date:  2005-07       Impact factor: 3.972

10.  circ_0030018 promotes glioma proliferation and metastasis.

Authors:  Yun Shao; Zhengxiang Yang; Weifeng Miao; Xiangrong Yu; Yiping Wu; Yi Pu
Journal:  Transl Neurosci       Date:  2021-06-09       Impact factor: 1.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.